AGL 38.20 Increased By ▲ 0.05 (0.13%)
AIRLINK 129.30 Increased By ▲ 4.23 (3.38%)
BOP 7.85 Increased By ▲ 1.00 (14.6%)
CNERGY 4.66 Increased By ▲ 0.21 (4.72%)
DCL 8.35 Increased By ▲ 0.44 (5.56%)
DFML 38.86 Increased By ▲ 1.52 (4.07%)
DGKC 82.20 Increased By ▲ 4.43 (5.7%)
FCCL 33.64 Increased By ▲ 3.06 (10.01%)
FFBL 75.75 Increased By ▲ 6.89 (10.01%)
FFL 12.83 Increased By ▲ 0.97 (8.18%)
HUBC 110.72 Increased By ▲ 6.22 (5.95%)
HUMNL 14.03 Increased By ▲ 0.54 (4%)
KEL 5.22 Increased By ▲ 0.57 (12.26%)
KOSM 7.69 Increased By ▲ 0.52 (7.25%)
MLCF 40.08 Increased By ▲ 3.64 (9.99%)
NBP 72.51 Increased By ▲ 6.59 (10%)
OGDC 189.18 Increased By ▲ 9.65 (5.38%)
PAEL 25.74 Increased By ▲ 1.31 (5.36%)
PIBTL 7.38 Increased By ▲ 0.23 (3.22%)
PPL 153.45 Increased By ▲ 9.75 (6.78%)
PRL 25.52 Increased By ▲ 1.20 (4.93%)
PTC 17.92 Increased By ▲ 1.52 (9.27%)
SEARL 82.50 Increased By ▲ 3.93 (5%)
TELE 7.63 Increased By ▲ 0.41 (5.68%)
TOMCL 32.50 Increased By ▲ 0.53 (1.66%)
TPLP 8.48 Increased By ▲ 0.35 (4.31%)
TREET 16.74 Increased By ▲ 0.61 (3.78%)
TRG 56.01 Increased By ▲ 1.35 (2.47%)
UNITY 28.85 Increased By ▲ 1.35 (4.91%)
WTL 1.34 Increased By ▲ 0.05 (3.88%)
BR100 10,659 Increased By 569.2 (5.64%)
BR30 31,331 Increased By 1822.5 (6.18%)
KSE100 99,269 Increased By 4695.1 (4.96%)
KSE30 31,032 Increased By 1587.6 (5.39%)
Business & Finance

Aiming to restore reputation, China may struggle to win global trust on vaccine: EIU

  • EIU stated that given the logistical challenges of vaccine distribution, China will be at risk of overpromising and under-delivering.
Published January 6, 2021

Despite being the frontrunner in the COVI-19 vaccine race, China will struggle to win the trust among fellow advanced countries, stated the Economic Intelligence Unit (EIU) in its latest report titled Asia in 2021.

The report, while delving on China stated that a strong headline recovery in GDP growth in 2021 will obscure some of the challenges faced by China’s economy, even as it has successfully brought Covid-19 under control.

Sequential economic momentum will, in fact, be weak. This will reflect the lingering impact of the pandemic on jobs and incomes; a tightening bias in monetary and fiscal policy; and the effects of geopolitical strains on investor confidence, it said.

“We expect China to be among the first countries to begin large-scale distribution of a coronavirus (Covid-19) vaccine in 2021. Besides the benefits for its own population, China will aim to use the development of a vaccine to restore its international reputation, which has been battered by its status as the origin of Covid-19. In particular, China will hope global distribution of its vaccine can shore up its ties in the developing world, where it and Western countries, led by the US, will increasingly vie for influence,” said the report.

EIU stated that given the logistical challenges of vaccine distribution, China will be at risk of overpromising and under delivering. It could also struggle to build global trust in its vaccine, given a mixed domestic safety record.

The report also anticipated a property price slump looming in China’s third- and fourth tier cities. It said that a tightening monetary policy and a new risk-rating system for property firms will cause tremors in the property market in 2021.

“As the Chinese and world economies normalise, monetary policy in China will have a tightening bias this year. Rising market interest rates will increase house-financing costs for investors and dampen market speculation.”

“Furthermore, pressure on major property developers to cap their debt levels has grown, following the issuance of new risk regulations in August 2020. As evidenced by strains on Evergrande, China’s largest developer, this will lead to discounted selling of housing stock or a retreat from land purchasing to avoid cash-flow issues,” it said.

Comments

Comments are closed.